- Home
- RVPH vs SKYH Comparison
RVPH vs SKYH Comparison
Compare RVPH & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- SKYH
- Stock Information
- Founded
- RVPH 2006
- SKYH 2017
- Country
- RVPH United States
- SKYH United States
- Employees
- RVPH N/A
- SKYH N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- SKYH Military/Government/Technical
- Sector
- RVPH Health Care
- SKYH Industrials
- Exchange
- RVPH Nasdaq
- SKYH Nasdaq
- Market Cap
- RVPH 18.1M
- SKYH 343.5M
- IPO Year
- RVPH N/A
- SKYH N/A
- Fundamental
- Price
- RVPH $0.44
- SKYH $10.13
- Analyst Decision
- RVPH Strong Buy
- SKYH Strong Buy
- Analyst Count
- RVPH 6
- SKYH 2
- Target Price
- RVPH $4.50
- SKYH $14.25
- AVG Volume (30 Days)
- RVPH 18.7M
- SKYH 110.4K
- Earning Date
- RVPH 11-13-2025
- SKYH 11-11-2025
- Dividend Yield
- RVPH N/A
- SKYH N/A
- EPS Growth
- RVPH N/A
- SKYH N/A
- EPS
- RVPH N/A
- SKYH N/A
- Revenue
- RVPH N/A
- SKYH $20,919,000.00
- Revenue This Year
- RVPH N/A
- SKYH $118.09
- Revenue Next Year
- RVPH N/A
- SKYH $88.34
- P/E Ratio
- RVPH N/A
- SKYH N/A
- Revenue Growth
- RVPH N/A
- SKYH 94.38
- 52 Week Low
- RVPH $0.25
- SKYH $9.28
- 52 Week High
- RVPH $4.28
- SKYH $14.52
- Technical
- Relative Strength Index (RSI)
- RVPH 43.60
- SKYH 49.97
- Support Level
- RVPH $0.57
- SKYH $9.71
- Resistance Level
- RVPH $0.69
- SKYH $10.29
- Average True Range (ATR)
- RVPH 0.10
- SKYH 0.42
- MACD
- RVPH -0.02
- SKYH 0.00
- Stochastic Oscillator
- RVPH 3.11
- SKYH 39.42
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.